Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$9.99 – $10.95
2% from low
Sector
Asset Management
Exchange
ARCX
ETF
GENT actively invests in taxable fixed income securities both issued by US and domestic entities. These securities include US Treasurys, TIPS, US mortgage- and asset-backed securities, government debt, corporate bonds, preferred securities, floating rate notes, and agency bonds. The fund focuses on investment grade, intermediate-term debt, all with a weighted average duration equal to 150% of the Bloomberg Intermediate US Gov/Credit Index. Selection of constituents is based on a thorough review of macroeconomic data, interest rate patterns, and yield curve dynamics. Fundamental analysis with quantitative techniques is also utilized to mitigate risks. It is expected for the subadvisor to actively adjust the funds average maturity and duration to achieve its objective of maximum current income and strong total return potential in all market cycles.
www.genetronhealth.comNo one on the platform currently holds GENT.
No tracked institution reports a position in GENT as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-08-28 | $0.0359 | 2026-08-31 |
| 2026-07-30 | $0.0445 | 2026-07-31 |
| 2026-06-29 | $0.0357 | 2026-06-30 |
| 2026-05-28 | $0.0358 | 2026-05-29 |
| 2026-04-29 | $0.0343 | 2026-04-30 |
| 2026-03-30 | $0.0340 | 2026-03-31 |
| 2026-02-26 | $0.0327 | 2026-02-27 |
| 2026-01-29 | $0.0329 | 2026-01-30 |
| 2025-12-30 | $0.0373 | 2025-12-31 |
| 2025-11-26 | $0.0356 | 2025-11-28 |
No one on the platform has traded GENT yet.
| 2025-10-30 | $0.0350 | 2025-10-31 |
| 2025-09-29 | $0.0350 | 2025-09-30 |
| Execution date | Ratio |
|---|---|
| 2005-12-12 | 1-for-1000reverse |
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
GENT actively invests in taxable fixed income securities both issued by US and domestic entities. These securities include US Treasurys, TIPS, US mortgage- and asset-backed securities, government debt, corporate bonds, preferred securities, floating rate notes, and agency bonds. The fund focuses on investment grade, intermediate-term debt, all with a weighted average duration equal to 150% of the Bloomberg Intermediate US Gov/Credit Index. Selection of constituents is based on a thorough review of macroeconomic data, interest rate patterns, and yield curve dynamics. Fundamental analysis with quantitative techniques is also utilized to mitigate risks. It is expected for the subadvisor to actively adjust the funds average maturity and duration to achieve its objective of maximum current income and strong total return potential in all market cycles.
No constituent disclosure available for this fund yet.
$GENT $HSDT $MFH $XHG $XRT XHG is already showing signs of life, just needs volume!!! ⬇️⬇️⬇️⬇️
View on StockTwits ↗Lowest Volume Rated ETFs Per 11/5/2024’s Close: 1 – $GVUS 2 – $UNIY 3 – $SPAX 4 – $GENT 5 – $GGUS 6 – $USSH 7 – $JHHY 8 – $QVMM 9 – $MAYT 10 – $KEAT https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-11-5-2024/
View on StockTwits ↗$COWI crazy amounts of shares 160mil already! And watchers are rising! #pink!! $GENT $PHIL
View on StockTwits ↗$CELU Former CEO of Apple, former FDA Commissioner, Google Ventures Founder, and X-Prize Founder on the board of Celularity! Clinical trials for Covid, Cancers, and Crohn's. Brand new facility and using the PIPE and SPAC money to commercialize. Game Changer! Spun out of a division at $CELG and investments from $SRNE and $GENT. https://www.fiercebiotech.com/biotech/celgene-spin-off-debuts-big-names-big-bucks-and-big-hopes https://celularity.com/company/board-of-directors/
View on StockTwits ↗$ATNM is very exciting with huge pipeline and filing FDA PW weekly. Get ready folks. $KBIO $JNJ $MRK $GILD $EBS $AMGN $CBPO $GENT $MYGN
View on StockTwits ↗$LGND $UTHR $ALXN $EBS $JUNO $TRIL $GENT $BLUE $CERS $CERE $ARNA $MYL $BIOL $BIDU $KITE $RMTI $IONS $BIIB $AGEN
View on StockTwits ↗$ATNM is very exciting with huge pipeline and filing FDA PW weekly. Get ready folks. $KBIO $JNJ $MRK $GILD $EBS $AMGN $CBPO $GENT $MYGN
View on StockTwits ↗$GBSN due for big bounce! Look at link: $AMGN $GILD $EBS $LGND $CBPO $GENT $UTHR $ALXN $BSTC $AMAG http://stks.co/g34dv
View on StockTwits ↗$GENT http://stks.co/a1wX7 ThermoDox Phase 3 put on fastrack-already being sold in Asia.
View on StockTwits ↗$AMGN Cab Someone Share Why Paulson's Sudden Interest In $ENZY ? $BIIB $MYGN $GILD $GENT $CBPO $BSTC $CELG $ALXN $EBS He Bought 2.4Million
View on StockTwits ↗Nasdaq small stocks with Performance Year +500% are $ARWR $BCRX $CCIH $CSIQ $GENT $GSAT $HZNP $INSY $PLUG http://stks.co/r05Ol
View on StockTwits ↗5 top stocks on NASDAQ (Mar. 04): $UNAM, $GTIV, $GENT, $VSCP, $NURO http://stks.co/h0Luz
View on StockTwits ↗$ARWR $BCRX $BLDP $CCIH $CSIQ $GENT $GSAT $HZNP $INSY $PLUG $PRTA the small stocks with performance - Year +500% http://stks.co/d0Hzd
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.